Refanin Capsule

About Refanin 150 mg Capsule

Refanin 150 mg capsule is a medicine made by Opsonin Pharma Limited. It is an antibiotic that belongs to the anti-tubercular group of medicines.

There are 18 brands of Rifampicin listed in Bangladesh. The lowest listed price is Firifam 150 mg Tablet at ৳ 1 per unit.

What is Refanin 150 mg Capsule?

Refanin 150 mg is a capsule product of Opsonin Pharma Limited that contains Rifampicin. It is usually taken as part of a combination regimen for tuberculosis, and the doctor decides the exact dose and duration. Doctors prescribe it as one part of a combination treatment plan, and cultures are usually checked before therapy starts to confirm the bacteria respond to it. The doctor decides the exact dose and duration based on the patient's condition, weight, and other medicines.

Uses of Refanin

It is an antibiotic that belongs to the anti-tubercular group of medicines. Only a qualified doctor can decide whether this medicine is suitable for a particular person and how it should fit into the overall treatment plan. Doctors may take samples for culture before starting therapy to confirm that the bacteria respond to Rifampicin. Whether it suits a particular person depends on the diagnosis and on other medicines being taken, so the treating doctor makes that decision.

How to use Refanin

Swallow with a full glass of water. Refanin is taken by mouth. If you are unsure how to take it, ask your doctor or pharmacist. Do not stop or change the schedule without medical advice. The dose and duration of treatment depend on your individual condition and will be decided by your doctor.

Side effects of Refanin

It may also cause flu-like symptoms such as fever, chills, headache, and dizziness. Serious effects include liver problems, blood disorders, kidney problems, and severe skin reactions. Rarely, eye irritation may occur. Contact your doctor if you notice yellowing of the eyes or skin, dark urine, severe tiredness, or any unusual bleeding or bruising. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

People with impaired liver function should receive Rifampicin only if necessary, with caution and strict medical supervision, and liver function tests may be checked before and during treatment. Do not start or stop this medicine without your doctor's guidance. Breastfeeding decisions are made with the doctor. Keep out of reach of children.

Frequently asked questions

Why is Refanin prescribed?

It is an antibiotic that belongs to the anti-tubercular group of medicines. Only a qualified doctor can decide whether this medicine is suitable for a particular person and how it should fit into the overall treatment plan.

How should I take Refanin?

Swallow with a full glass of water. Refanin is taken by mouth.

Can Refanin cause side effects?

It may also cause flu-like symptoms such as fever, chills, headache, and dizziness. Serious effects include liver problems, blood disorders, kidney problems, and severe skin reactions.

Who should be careful with Refanin?

People with impaired liver function should receive Rifampicin only if necessary, with caution and strict medical supervision, and liver function tests may be checked before and during treatment. Do not start or stop this medicine without your doctor's guidance.

Also available as

450 mg (Capsule)

Indications

In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the ... Read moreIn the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampinand they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to rifampin and the patient is not responding to therapy, the drug regimen should be modified.

Pharmacology

Rifampicin suppresses initiation of chain formation for RNA synthesis in susceptible bacteria by binding to the β subunit of DNA-dependent RNA polymerase, thus blocking RNA transcription.

Dosage & Administration

Rifampin can be administered by the oral route or by IV infusion. IV doses are the same as those for oral.

Tuberculosis:
  • Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
  • Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
It is recommended that oral rifampin be administered once daily, either 1 hour before or 2 hours after a meal with a full glass of water.

Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.

Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.

Interaction

May accelerate the metabolism and reduce the effect of drugs that are metabolised by CYP450 enzymes (e.g. quinidine, phenytoin, theophylline). Decreased concentrations of atovaquone and increased concentrations of rifampicin when taken concomitantly. Concurrent use of ketoconazole and rifampicin may result in decreased serum concentrations of both drugs. May decrease serum concentrations of enalaprilat. Reduced absorption by antacids. Increased risk of hepatotoxicity with halothane or isoniazid.

Contraindications

Rifampicin is contraindicated in patients with a history of hypersensitivity to rifampin or any of the components, or to any of the rifamycins. Rifampin is contraindicated in patients who are also receiving ritonavir-boosted saquinavir due to an increased risk of severe hepatocellular toxicity.

Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.

Side Effects

Facial flushing and itching, with or without a rash, flu-like syndrome characterised by episodes of fever, chills, headache, dizziness, bone pain, shortness of breath, and malaise; GI adverse effects (e.g. nausea, vomiting, anorexia, diarrhoea, epigastric distress), pseudomembranous colitis, eosinophilia, leucopenia, haemolytic anaemia; alterations in kidney function and renal failure, menstrual disturbances, oedema, myopathy, muscular weakness; orange-red discolouration of the urine, faeces, sweat, saliva, sputum, tears, and other body fluids; thrombophlebitis, local irritation and inflammation after prolonged IV infusion. Rarely, eye irritation and visual disturbances, anaphylaxis or shock.

Pregnancy & Lactation

Pregnancy: When administered during the last few weeks of pregnancy, rifampin can cause post natal hemorrhages in the mother and infant for which treatment with vitamin K may be indicated.

Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

Rifampicin has been shown to produce liver dysfunction. Fatalities associated with jaundice have occurred in patients with liver disease and in patients taking rifampin with other hepatotoxic agents. Patients with impaired liver function should be given rifampin only in cases of necessity and then with caution and under strict medical supervision. In these patients, careful monitoring of liver function, especially SGPT/ALT and SGOT/AST should be carried out prior to therapy and then every 2 to 4 weeks during therapy. If signs of hepatocellular damage occur, rifampin should be withdrawn.

In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.

Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.

Overdose Effects

Nausea, vomiting, abdominal pain, pruritus, headache, and increasing lethargy will probably occur within a short time after ingestion; unconsciousness may occur when there is severe hepatic disease. Transient increases in liver enzymes and/or bilirubin may occur. Brownish-red or orange discoloration of the skin, urine, sweat, saliva, tears, and feces will occur, and its intensity is proportional to the amount ingested.

Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.

Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.

Storage Conditions

Store between 15-30° C. Avoid excessive heat and protect from light.

Alternative brands of Rifampicin

Other brands with the same generic name, cheapest first.

Firifam Tablet

150 mg

Rifampicin

Synovia Pharma PLC.

৳ 0.98 ৳ 1 2% off per unit

Firifam Tablet

450 mg

Rifampicin

Synovia Pharma PLC.

৳ 0.98 ৳ 1 2% off per unit

Rifcin Capsule

150 mg

Rifampicin

Pharmadesh Laboratories Ltd.

৳ 10.81 ৳ 11.03 2% off per unit

Rifatan Syrup

100 mg/5 ml

Rifampicin

G. A. Company Ltd.

৳ 28.8 ৳ 29.39 2% off per unit

Rifcin Syrup

100 mg/5 ml

Rifampicin

Pharmadesh Laboratories Ltd.

৳ 78.4 ৳ 80.00 2% off per unit

See all 18 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.